News | January 08, 2014

MarketsandMarkets Report Analyzes MR Market Values

mri systems marketsandmarkets
January 8, 2014 — The report, "Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) — Technology Trend Analysis — By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis — Estimates up to 2018," by MarketsandMarkets, analyzes and studies the major technology and market drivers, restraints and opportunities in North America, Europe, Asia and Rest of the World.
 
The global MR systems market was valued at $4 billion and $4.1 billion in 2011 and 2012, respectively. As of March 2013, the market is expected to be $4.13 billion and is poised to reach approximately $5.24 billion by 2018 at a compound annual growth rate (CAGR) of 4.56 percent.
 
The global healthcare industry is witnessing a paradigm shift, skewed towards noninvasive and non-ionizing diagnostic procedures, which not only cure serious illnesses, but also have negligible side effects. MRI is one of such technologies with the potential to revolutionize medical diagnostics in healthcare.
 
This market research report evaluates the global market of MRI by architecture, field strength, technology, application and geography. The architecture MRI market is further categorized as closed and open MRI systems; the field strength segment comprises low to mid-field strength, high field strength and very high field strength MR systems, the technology segment is classified as MR angiogram, MR venogram, functional MRI, MR spectroscopy and fusion MR, while the application segment covers breast MRI, cardiac MRI, interventional MRI, whole body MRI and MRI for brain and neurological disorders.
 
Closed systems with high field strengths dominate the market due to their high clinical significance and higher image resolution. Technological advancements such as the introduction of MRI-compatible pacemakers and digital broadband scanners drive the growth of the MRI market. Aging population in developed countries and increasing cases of chronic diseases in developing economies accelerates the market growth from the demand side.
 
The use of MRI technology is expected to dilate globally, owing to its significance in modern medical diagnosis for diverse biomedical applications. MRI systems for neurology and brain disorders command the current market, while cardiac MRI and breast MR systems are gaining momentum, due to rising cardiac and breast cancer cases globally.
 
With its ability to image anatomically and functionally, MRI has found its way into surgical applications as well as diffusion and perfusion imaging. It is being combined with other modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT) and ultrasound to achieve new heights of image clarity.
 
The report can be found here.
 
For more information: www.marketsandmarkets.com

Related Content

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...

Photo courtesy of Philips Healthcare

Feature | Radiology Business | May 31, 2019 | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look.
MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...